Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 214

1.

Double immunization strategy with a BoHV-4-vectorialized secreted chimeric peptide BVDV-E2/BoHV-1-gD.

Donofrio G, Sartori C, Franceschi V, Capocefalo A, Cavirani S, Taddei S, Flammini CF.

Vaccine. 2008 Nov 11;26(48):6031-42. doi: 10.1016/j.vaccine.2008.09.023. Epub 2008 Sep 21.

PMID:
18812200
2.

Establishment of a bovine herpesvirus 4 based vector expressing a secreted form of the bovine viral diarrhoea virus structural glycoprotein E2 for immunization purposes.

Donofrio G, Sartori C, Ravanetti L, Cavirani S, Gillet L, Vanderplasschen A, Taddei S, Flammini CF.

BMC Biotechnol. 2007 Oct 18;7:68.

3.

Cellular targeting of engineered heterologous antigens is a determinant factor for bovine herpesvirus 4-based vaccine vector development.

Donofrio G, Franceschi V, Capocefalo A, Taddei S, Sartori C, Bonomini S, Cavirani S, Cabassi CS, Flammini CF.

Clin Vaccine Immunol. 2009 Nov;16(11):1675-86. doi: 10.1128/CVI.00224-09. Epub 2009 Sep 30.

4.

Immunization with plasmid DNA encoding a truncated, secreted form of the bovine viral diarrhea virus E2 protein elicits strong humoral and cellular immune responses.

Liang R, van den Hurk JV, Zheng C, Yu H, Pontarollo RA, Babiuk LA, van Drunen Littel-van den Hurk S.

Vaccine. 2005 Nov 1;23(45):5252-62. Epub 2005 Jul 13.

PMID:
16154245
5.

Recombinant bovine herpesvirus 4 (BoHV-4) expressing glycoprotein D of BoHV-1 is immunogenic and elicits serum-neutralizing antibodies against BoHV-1 in a rabbit model.

Donofrio G, Cavirani S, Vanderplasschen A, Gillet L, Flammini CF.

Clin Vaccine Immunol. 2006 Nov;13(11):1246-54. Epub 2006 Aug 23.

6.
7.

Compatibility of plasmids encoding bovine viral diarrhea virus type 1 and type 2 E2 in a single DNA vaccine formulation.

Liang R, Babiuk LA, van Drunen Littel-van den Hurk S.

Vaccine. 2007 Aug 10;25(32):5994-6006. Epub 2007 Jun 11.

PMID:
17597267
8.

Recombinant bovine adenovirus type 3 expressing bovine viral diarrhea virus glycoprotein E2 induces an immune response in cotton rats.

Baxi MK, Deregt D, Robertson J, Babiuk LA, Schlapp T, Tikoo SK.

Virology. 2000 Dec 5;278(1):234-43.

9.

Sequence-optimised E2 constructs from BVDV-1b and BVDV-2 for DNA immunisation in cattle.

Couvreur B, Letellier C, Olivier F, Dehan P, Elouahabi A, Vandenbranden M, Ruysschaert JM, Hamers C, Pastoret PP, Kerkhofs P.

Vet Res. 2007 Nov-Dec;38(6):819-34. Epub 2007 Aug 31.

10.

A chimeric baculovirus displaying bovine herpesvirus-1 (BHV-1) glycoprotein D on its surface and their immunological properties.

Peralta A, Molinari P, Conte-Grand D, Calamante G, Taboga O.

Appl Microbiol Biotechnol. 2007 May;75(2):407-14. Epub 2007 Feb 7.

PMID:
17285288
11.

DNA prime protein boost strategies protect cattle from bovine viral diarrhea virus type 2 challenge.

Liang R, van den Hurk JV, Landi A, Lawman Z, Deregt D, Townsend H, Babiuk LA, van Drunen Littel-van den Hurk S.

J Gen Virol. 2008 Feb;89(Pt 2):453-66. doi: 10.1099/vir.0.83251-0.

PMID:
18198376
12.

A combined bovine herpesvirus 1 gB-gD DNA vaccine induces immune response in mice.

Caselli E, Boni M, Di Luca D, Salvatori D, Vita A, Cassai E.

Comp Immunol Microbiol Infect Dis. 2005 Mar;28(2):155-66.

PMID:
15582691
13.

Construction and characterization of E3-deleted bovine adenovirus type 3 expressing full-length and truncated form of bovine herpesvirus type 1 glycoprotein gD.

Zakhartchouk AN, Reddy PS, Baxi M, Baca-Estrada ME, Mehtali M, Babiuk LA, Tikoo SK.

Virology. 1998 Oct 10;250(1):220-9.

14.

Swine adipose stromal cells loaded with recombinant bovine herpesvirus 4 virions expressing a foreign antigen induce potent humoral immune responses in pigs.

Donofrio G, Taddei S, Franceschi V, Capocefalo A, Cavirani S, Martinelli N, Ottonello S, Ferrari M.

Vaccine. 2011 Jan 29;29(5):867-72. doi: 10.1016/j.vaccine.2010.11.048. Epub 2010 Nov 27.

PMID:
21115049
15.

Evaluation of efficacy of mammalian and baculovirus expressed E2 subunit vaccine candidates to bovine viral diarrhoea virus.

Thomas C, Young NJ, Heaney J, Collins ME, Brownlie J.

Vaccine. 2009 Apr 14;27(17):2387-93. doi: 10.1016/j.vaccine.2009.02.010. Epub 2009 Feb 12.

PMID:
19428855
16.

Immune response to vaccination with DNA encoding the bovine viral diarrhea virus major glycoprotein gp53 (E2).

Harpin S, Talbot B, Mbikay M, Elazhary Y.

FEMS Microbiol Lett. 1997 Jan 15;146(2):229-34.

17.

Generation of a transposon insertion mutant library for bovine herpesvirus 4 cloned as a bacterial artificial chromosome by in vitro MuA based DNA transposition system.

Donofrio G, Martignani E, Sartori C, Vanderplasschen A, Cavirani S, Flammini CF, Gillet L.

J Virol Methods. 2007 Apr;141(1):63-70. Epub 2006 Dec 19.

PMID:
17182112
18.

Biological characterization of bovine herpesvirus 1 recombinants possessing the vaccine glycoprotein E negative phenotype.

Muylkens B, Meurens F, Schynts F, de Fays K, Pourchet A, Thiry J, Vanderplasschen A, Antoine N, Thiry E.

Vet Microbiol. 2006 Mar 31;113(3-4):283-91.

PMID:
16321480
19.

Evaluation of the vaccine potential of an equine herpesvirus type 1 vector expressing bovine viral diarrhea virus structural proteins.

Rosas CT, König P, Beer M, Dubovi EJ, Tischer BK, Osterrieder N.

J Gen Virol. 2007 Mar;88(Pt 3):748-57.

PMID:
17325347
20.

Efficacy of a BVDV subunit vaccine produced in alfalfa transgenic plants.

Peréz Aguirreburualde MS, Gómez MC, Ostachuk A, Wolman F, Albanesi G, Pecora A, Odeon A, Ardila F, Escribano JM, Dus Santos MJ, Wigdorovitz A.

Vet Immunol Immunopathol. 2013 Feb 15;151(3-4):315-24. doi: 10.1016/j.vetimm.2012.12.004. Epub 2012 Dec 17.

PMID:
23291101

Supplemental Content

Support Center